-transparent.png){kind=logo}
The synergistic effects of stem cell factor (SCF) in combination with other growth factors including interleukin (IL)-6, IL-11, IL-3, GM-CSF, G-CSF, IL-1 alpha and interferon-gamma (IFN-gamma) on the expansion of murine hematopoietic progenitors were studied in a short-term liquid suspension culture system. Bone marrow (BM) cells obtained 2 days after 5-fluorouracil (5-FU) injection were cultured for up to 18 days in serum-containing and serum-free cultures in the presence of combinations of various cytokines. The numbers of nucleated cells, total colony-forming cells (CFC), mixed-colony forming units (CFU-Mix) and high-proliferative potential colony-forming cells (HPP-CFC) before and after liquid suspension cultures were measured in the presence of different combinations of cytokines. Combinations of SCF with IL-11, IL-6 or IL-1 alpha markedly increased the numbers of total CFC, CFU-Mix and HPP-CFC. A combination of SCF and IL-3 also expanded the number of total CFC; however, the fold increase was smaller than those of SCF plus IL-11, IL-6 or IL-1 alpha. Three or four factor combinations including SCF with IL-3, IL-6 and IL-11 did not yield increased numbers of total CFC over that supported by SCF plus either IL-6 or IL-11. The addition of IFN-gamma to the culture containing SCF plus IL-11 resulted in a decrease of the expansion efficiency. However, this difference is not statistically significant. In contrast, the addition of IFN-gamma to the cultures containing SCF plus IL-6 did not affect the expansion efficiency. Interestingly, the addition of IL-1 alpha in the culture containing SCF plus IL-3 significantly increased the number of HPP-CFC over that supported by SCF plus IL-3 (p < 0.01). In contrast, IL-1 alpha did not significantly affect the expansion efficiency in the presence of SCF plus IL-6 or IL-11. These results suggest that combinations of SCF plus either IL-6 or IL-11 or a combination of SCF, IL-3 and IL-1 alpha can most effectively expand murine hematopoietic progenitors derived from day-2 post-5-FU BM cells in vitro.
Y Ariyama, and
S Misawa, and
Y Sonoda
April 1994,
Experimental hematology,
Y Ariyama, and
S Misawa, and
Y Sonoda
June 1994,
Experimental hematology,
Y Ariyama, and
S Misawa, and
Y Sonoda
September 1992,
[Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Y Ariyama, and
S Misawa, and
Y Sonoda
February 1991,
Proceedings of the National Academy of Sciences of the United States of America,
Y Ariyama, and
S Misawa, and
Y Sonoda
September 1992,
Experimental hematology,
Y Ariyama, and
S Misawa, and
Y Sonoda
June 1990,
Blood,
Y Ariyama, and
S Misawa, and
Y Sonoda
March 1993,
Blood,
Y Ariyama, and
S Misawa, and
Y Sonoda
July 1992,
Blood,
Y Ariyama, and
S Misawa, and
Y Sonoda
October 1991,
Blood,
Y Ariyama, and
S Misawa, and
Y Sonoda
August 1991,
Journal of immunological methods,
